XTL Biopharmaceuticals Ltd.

Regulatory Filings • Feb 5, 2009

_________ false

C007��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996428Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 05/02/2009              Time of broadcast: 22:05 21:32:51

Reference: 2009-02-031341

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 11/03/2009 at 15:00 the corporation will hold it's special meetingat the Company�s Israeli offices at Building 3, Kiryat Weizmann Science Park, Rehovot, Israel 76100Number of the security that entitles its holder to vote at the meeting: 1085497The Number - as given by the Tel Aviv Stock Exchange

According to section 182 C of the Companies law, 5759-1999, only shareholders of record at the close of business 11/02/2009 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report Notice_of_EGM_FINAL_Feb_5-2009_FINAL_isa.pdf

Attached hereto is the proxy statement Proxy_Form_EGM_XTL_Israel_Final_Feb_5-2009_isa.pdf

This is a notice regarding the first out of two Extra Ordinary meetings of the company to be held at the same day. the second meeting shall take place at 17:30 at the same place.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 31/12/2008
- - -
Name of the Signatory: : Kantor Ronen , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary , Name of Employer Company: .
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2